174 related articles for article (PubMed ID: 8769300)
1. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
[TBL] [Abstract][Full Text] [Related]
2. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
[TBL] [Abstract][Full Text] [Related]
4. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
[TBL] [Abstract][Full Text] [Related]
5. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
[TBL] [Abstract][Full Text] [Related]
6. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
[TBL] [Abstract][Full Text] [Related]
8. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
9. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
[TBL] [Abstract][Full Text] [Related]
10. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
11. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
[TBL] [Abstract][Full Text] [Related]
14. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.
Wesche B; Jaeckel E; Trautwein C; Wedemeyer H; Falorni A; Frank H; von zur Mühlen A; Manns MP; Brabant G
Gut; 2001 Mar; 48(3):378-83. PubMed ID: 11171829
[TBL] [Abstract][Full Text] [Related]
15. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
[TBL] [Abstract][Full Text] [Related]
16. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha.
Christodoulou D; Christou L; Zervou E; Katsanos K; Kitsanou M; Tsianos EV
Hepatogastroenterology; 2007 Sep; 54(78):1761-5. PubMed ID: 18019713
[TBL] [Abstract][Full Text] [Related]
19. Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis.
Falaschi P; D'Urso R; Proietti A; Martocchia A; Pastore R; Angelucci L
Life Sci; 1997; 60(1):43-50. PubMed ID: 8995531
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic viral hepatitis.
Marcellin P; Benhamou JP
Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
